This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

North America and Europe Artificial Pancreas Systems Market

Market Insights on North America and Europe Artificial Pancreas Systems covering sales outlook, demand forecast & up-to-date key trends

North America and Europe Artificial Pancreas Systems Market By Distribution Channel Type (Hospitals, E-Commerce), Disease Indication (Diabetes Type 1, Diabetes Type 2) & Region - Forecast to 2016 - 2026

Diabetes Type 1 segment is likely to prevail over Diabetes Type 2 segment in the North America and Europe artificial pancreas systems market

The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016.

The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.6% over the forecast period to reach more than US$ 250 Mn by 2026. On the other hand the Diabetes Type 2 segment is expected to register low Y-o-Y growth rates throughout the forecast period.

Revenue contribution of this segment to the North America and Europe artificial pancreas systems market is expected to increase at a CAGR of 4.1% over the forecast period. The Diabetes Type 1 segment dominated the North America and Europe artificial pancreas systems market in revenue terms in 2015, and the trend is projected to continue throughout the forecast period.

The Diabetes Type 2 segment is expected to remain the least attractive segment in the North America and Europe artificial pancreas systems market in revenue terms with a low market attractiveness index of 0.02 over the forecast period. 

Customize this Report

Let us know your requirement to get
100% FREE customization

Alarming rise in population and economic burden of diabetes worldwide is anticipated to impact the artificial pancreas systems market in North America and Europe

Diabetes is one of the chronic and life-threatening diseases that affects a large part of the global population. Diabetes, also known as diabetes mellitus, is a metabolic disorder wherein the pancreas are either not able to produce insulin or the body is not able to utilise the existing insulin to metabolise glucose. Insulin is an essential secretion (hormone) of the body that metabolises glucose received by the body during and after a meal. An increasing burden of managing and controlling diabetes is the most important factor prompting demand for artificial pancreas systems among the global diabetic population. 

Conventional systems used for diabetes management have many drawbacks including the need to take insulin injections at multiple times and recalibrating the CGM devices, thereby making management of diabetes quite tedious. However, artificial pancreas systems are designed to be more portable and user friendly. Artificial pancreas systems are technologically advanced.

North America and Europe Artificial Pancreas Systems Market Download Report Brochure

On the other hand, the conventional insulin pumps or CGM devices are large in size and thus, people have social and psychological stigma regarding conventional insulin devices, which motivates them to opt for artificial pancreas systems. This particular factor is creating a robust development in the North America and Europe artificial pancreas systems market. 

Artificial pancreas systems are envisioned to deliver a complete system known as a closed loop system that mimics a pancreatic activity of maintaining blood glucose levels by coalescing several technologies including a glucose monitoring device, a glucose sensor with cutting-edge algorithm software and an insulin pump. Manufacturers are competing to provide such high-end artificial pancreas systems to attract diabetic patients who intend to improve diabetes management.  

Diabetes Type 1 segment is projected to dominate the North America and Europe artificial pancreas systems market throughout the period of assessment

Diabetes Type 1 disease indication segment dominated the North America artificial pancreas systems market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period, recording a market attractiveness index of 2.0. In Western and Eastern Europe this segment is expected to remain the dominant disease indication segment throughout the projected period. 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

North America and Europe artificial pancreas systems market: segmentation

By Region:

  • North America
  • Western Europe
  • Eastern Europe

By Distribution Channel:

  • Hospitals
  • E-Commerce

By Disease Indication:

  • Diabetes Type 1
  • Diabetes Type 2
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

Demand for North America and Europe artificial pancreas systems is likely to grow at a CAGR of 12% through 2032.

Sales of North America and Europe artificial pancreas systems is likely to exceed a valuation of US$ 567.47 million by 2032.

Adoption of North America and Europe artificial pancreas systems is likely to reach a valuation of US$ 182.71 million in 2022.

Upsurge in the case of type-1 diabetes is leading to North America and Europe artificial pancreas systems market growth.

Table of Content

1.  Executive Summary

2.  Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3.  North America and Europe Artificial Pancreas Device System Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

3.3. Market Overview

4.  Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

5. North America and Europe Artificial Pancreas Device System Market Analysis and Fore casts, By Disease Indication 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Disease Indication 

5.3. Y-o-Y Growth Projections By Disease Indication 

5.4. Market Value Forecast By Disease Indication, 2016–2026

5.4.1. Diabetes Type 1

5.4.2. Diabetes Type 2

5.5. Prominent Trends

5.6. Market Attractiveness By Disease Indication 

6. North America and Europe Artificial Pancreas Device System Market Analysis and Forecast, By Distribution Channel  

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By  Distribution Channel 

6.3. Y-o-Y Growth Projections By Distribution Channel 

6.4. Market Value Forecast By Distribution Channel, 2016–2026

6.4.1. Hospitals

6.4.2. E-Commerce

6.5. Drivers and Restraints: Impact Analysis

6.6. Market Attractiveness By Distribution Channel  

7. North America and Europe Artificial Pancreas Device System Market Analysis and Forecasts, By Region

7.1. Basis Point Share (BPS) Analysis By Country

7.2. Y-o-Y Growth Projections By Country

7.3. Market Value Forecast By Region

7.3.1. North America 

7.3.2. Western Europe 

7.3.3. Eastern Europe 

7.4. Market Attractiveness By Country/Region

8. North America Artificial Pancreas Device System Market Analysis and Forecast

8.1. Introduction

8.1.1. Basis Point Share (BPS) Analysis By Country

8.1.2. Y-o-Y Growth Projections By Country

8.1.3. Key Regulations

8.2. Market Value Forecast By Disease Indication, 2016–2026

8.2.1. Diabetes Type 1

8.2.2. Diabetes Type 2

8.3. Market Value Forecast By Distribution Channel, 2016–2026

8.3.1. Hospitals

8.3.2. E-Commerce

8.4. Market Value Forecast By Country, 2016–2026

8.4.1. The U.S.

8.4.2. Canada

8.5. Market Attractiveness Analysis 

8.5.1. By Disease Indication 

8.5.2. By Distribution Channel  

8.5.3. By Country

8.6. Drivers and Restraints: Impact Analysis

9. Western Europe Artificial Pancreas Device System Market Analysis and Forecast

9.1.Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2.Market Value Forecast By Disease Indication, 2016–2026

9.2.1. Diabetes Type 1

9.2.2. Diabetes Type 2

9.3.Market Value Forecast By Distribution Channel, 2016–2026

9.3.1. Hospitals

9.3.2. E-Commerce

9.4.Market Value Forecast By Country, 2016–2026

9.4.1. Germany 

9.4.2. France

9.4.3. Italy

9.4.4. Spain

9.4.5. The U.K.

9.4.6. BENELUX

9.4.7. Rest of Western Europe

9.5.Market Attractiveness Analysis 

9.5.1. By Disease Indication 

9.5.2. By Distribution Channel  

9.5.3. By Country

9.6. Drivers and Restraints: Impact Analysis

10. Eastern Europe Artificial Pancreas Device System Market Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2.Market Value Forecast By Disease Indication, 2016–2026

10.2.1. Diabetes Type 1

10.2.2. Diabetes Type 2

10.3.Market Value Forecast By Distribution Channel, 2016–2026

10.3.1. Hospitals

10.3.2. E-Commerce

10.4.Market Value Forecast By Country, 2016–2026

10.4.1. Russia

10.4.2. Poland

10.4.3. Rest of Eastern Europe

10.5.Market Attractiveness Analysis 

10.5.1. By Disease Indication

10.5.2. By Distribution Channel  

10.5.3. By Country

10.6. Prominent Trends 

10.7. Drivers and Restraints: Impact Analysis 

11. Competition Landscape

11.1.Competition Dashboard

11.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

11.2.1. Medtronic Plc.

11.2.2. Johnson and Johnson Services Inc.

11.2.3. Dexcom Inc.

11.2.4. Insulet Corporation

11.2.5. Tandem Diabetes Care Inc.

11.2.6. Cellnovo

12. Assumptions and Acronyms Used

13. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: List of artificial pancreas device system (APDS) in pipeline

Table 2: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026

Table 3: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 4: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2026

Table 5: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026

Table 6: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026

Table 7: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026

Table 8: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026

Table 9: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026

Table 10: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026

Table 11: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026

Table 12: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026

Table 13: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Forecast 2016 and 2026

Figure 2 : North America and Europe Artificial Pancreas Device System Market Split By Disease Indication (2015)

Figure 3 : North America and Europe Artificial Pancreas Device System Market Split By Distribution Channel (2015)

Figure 4: North America and Europe Artificial Pancreas Device System Market Split By Region (2015)

Figure 5: North America and Europe Artificial Pancreas Device System Market Value Analysis and Forecast, 2015–2026 (US$ Mn)

Figure 6: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Disease Indication, 2016 & 2026

Figure 7: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) Disease Indication, 2016 & 2026

Figure 8: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Disease Indication, 2015–2026 

Figure 9: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Diabetes Type 1, 2015 – 2026

Figure 10: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) Segment, By Diabetes Type 2 2015 –2026

Figure 11: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication, 2016–2026 

Figure 12: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Distribution Channel, 2016 & 2026

Figure 13: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Distribution Channel, 2016 & 2026

Figure 14: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Distribution Channel, 2015–2026 

Figure 15: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Hospitals Segment, 2015 – 2026

Figure 16: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By E-Commerce Segment, 2015 – 2026

Figure 17: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel, 2016–2026 

Figure 18: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Region, 2016 & 2026

Figure 19: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Region, 2016 & 2026

Figure 20: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Region, 2015–2026 

Figure 21: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 22: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 23: Eastern Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 24: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Region, 2016–2026 

Figure 25: North America Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026

Figure 26: North America Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 27: U.S. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 28: Canada Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 29: North America Artificial Pancreas Device System Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 30: North America Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication 2016 – 2026 

Figure 31: North America Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel 2016 – 2026 

Figure 32: Western Europe Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026

Figure 33: Western Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 34: Germany Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure  35: France Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 36: Italy Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 37: Spain Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 38: The U.K. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pancreatic Elastase Testing Market

Published : October 2021

Healthcare

Pancreatic Stone Protein Testing Market

Published : October 2019

Healthcare

Pancreatic Cyst Diagnostics Market

Published : June 2019

Healthcare

Artificial Pancreas Device System Market

Published : March 2022

Google translate

North America and Europe Artificial Pancreas Systems Market